Christopher Peetz - CHIEF EXECUTIVE OFFICER, Director at Mirum Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CHIEF EXECUTIVE OFFICER, Director
Issuer Symbol
MIRM on Nasdaq
All Insider Reports
All Insider Reports

Christopher Peetz - trading volume in the past year for Mirum Pharmaceuticals, Inc.

Holdings reported by Christopher Peetz for Mirum Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 187,500 $13,711,875 $73.13 31 Dec 2025 By The Peetz Family Trust
Common Stock 158,034 $11,557,026 $73.13 31 Dec 2025 Direct
Restricted Stock Units 25,000 $1,198,108 $47.92 23 Jan 2025 Direct Common Stock
Stock Option (right to buy) 153,550 21 Jan 2025 Direct Common Stock
Employee Stock Option (right to buy) 150,867 18 Nov 2025 Direct Common Stock
Performance Restricted Stock Units 25,000 15 Mar 2025 Direct Common Stock

Transactions reported by Christopher Peetz for Mirum Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.